HEPATITIS B, CHRONIC
Clinical trials for HEPATITIS B, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control stubborn hepatitis b
Disease control CompletedThis study tested a two-step treatment for adults with chronic Hepatitis B who were already on standard antiviral pills. First, participants received an investigational injection (an ASO) for 12 or 24 weeks to try to lower the virus. Then, they received an investigational immunot…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo aims to knock out hepatitis b virus
Disease control CompletedThis study tested several new drug combinations to see if they could safely control and potentially clear the hepatitis B virus in adults. It involved 33 people with chronic hepatitis B who had not taken certain standard treatments before. Researchers measured whether the virus b…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Scientists test drug cocktails in quest for functional cure for hepatitis b
Disease control CompletedThis study tested several new combination drug therapies to see if they could help control and potentially clear chronic Hepatitis B infection. It involved 281 adults with stable liver function who were already on standard antiviral medication. The main goal was to see if the new…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC